Enteric Empty Capsules Market Trends: Rising Demand & Forecast
페이지 정보
본문
Enteric Empty Capsules Market Size :
Enteric Empty Capsules Market size is estimated to reach over USD 156.85 Million by 2032 from a value of USD 83.13 Million in 2024 and is projected to grow by USD 88.51 Million in 2025, growing at a CAGR of 8.30 % from 2025 to 2032.
Enteric Empty Capsules Market Analysis Overview:
The enteric empty capsules market focuses on the production and distribution of capsules designed to resist dissolution in the acidic environment of the stomach and release their contents in the alkaline environment of the intestines. These capsules are crucial for delivering sensitive drugs, probiotics, and nutraceuticals that could be degraded or cause irritation in the stomach. The market is driven by the growing pharmaceutical and nutraceutical industries, the increasing demand for targeted drug delivery, and advancements in capsule manufacturing technologies.
Key Drivers:
· Growing pharmaceutical industry: The increasing development and production of drugs requiring enteric release are driving market growth.
· Rising nutraceutical demand: The growing popularity of probiotics, enzymes, and other nutraceuticals that benefit from enteric delivery is boosting market demand.
· Targeted drug delivery: Enteric capsules enable precise drug delivery to the intestines, improving efficacy and reducing side effects.
· Advancements in capsule technology: Innovations in materials and manufacturing processes are leading to improved capsule performance and stability.
· Enteric empty capsules are largely essential for providing supplements and medications in treating chronic diseases. Owing to certain features of the capsules such as accurate dosage and compatibility with different kinds of drugs, the capsules are largely required in treatments for chronic conditions.
· Moreover, as per the analysis, increasing cases of cancer, heart disease, diabetes, respiratory illness, and neurovascular stroke globally are leading to driving the requirement for enteric empty capsules market.
Key Restraints:
· High production costs: The specialized manufacturing processes and materials used for enteric capsules can increase production costs.
· Regulatory requirements: Stringent regulatory standards for pharmaceutical and nutraceutical products can increase compliance costs.
· Material compatibility challenges: Ensuring compatibility between the capsule material and the encapsulated drug or nutraceutical is crucial but can be challenging.
· Moisture sensitivity: Some enteric coatings can be sensitive to moisture, requiring careful handling and storage.
· Enteric empty capsules have gelatin as the most common material used in the production process. Gelatin is prepared from collagen, which is made from the by-products of slaughtered animals which include bones, hides, hooves of cattle, fish, pigs, horses, and others.
· Hence, due to certain dietary restrictions and cultural practices followed by different individuals, the enteric empty capsules market growth is getting hampered to a certain extent.
Future Opportunities:
The enteric empty capsules market presents several growth opportunities:
· Development of novel enteric coating materials: Research into new biocompatible and biodegradable coating materials with improved performance.
· Expansion into personalized medicine: Tailoring enteric capsules to meet the specific needs of individual patients.
· Integration with advanced drug delivery systems: Combining enteric capsules with other drug delivery technologies, such as nanoparticles and microencapsulation.
· Expansion into emerging markets: Increasing demand for high-quality capsules in developing countries with growing pharmaceutical and nutraceutical industries.
· Different innovations in capsule manufacturing technology such as the development of automated capsule filling machines and others are expected to boost the enteric empty capsules market opportunities and trends further.
· They launched a new product named EUDRACAP, which is suitable for early drug development stages through a commercial scale and by using sensitive molecules.
· Thus, different advancements in capsule design and materials by the key players of the market are improving the drug delivery process, enhancing product quality, improving patient compliance, and others.
Segmentation:
The enteric empty capsules market can be segmented based on:
Material:
· Gelatin
· HPMC (Hydroxypropyl Methylcellulose)
· Pullulan
Coating Material:
· Cellulose Acetate Phthalate (CAP)
· Hypromellose Phthalate (HPMCP)
· Acrylate Polymers
Application:
· Pharmaceuticals
· Nutraceuticals
· Dietary Supplements
Type:
· Gelatin
· Non-Gelatin
Key Players:
· Lonza Group Ltd, Evonik
· The Roxlor Group
· CapsCanada Corporation
· Qualicaps Inc.
· CapsulCN International Co.
· Ltd., Natural Capsules Limited
· Snail Pharma Industry Co. Ltd, ACG Group
· Anhui Huangshan Capsule Co., Ltd.
Regional Analysis:
The North American and European markets are currently leading the global enteric empty capsules market due to well-established pharmaceutical and nutraceutical industries. The Asia-Pacific region is expected to witness significant growth due to increasing healthcare expenditure and pharmaceutical production.
Recent Developments:
Development of plant-based enteric capsules: Manufacturers are focusing on developing vegan-friendly and plant-based enteric capsules using materials like HPMC and pullulan.
Development of customized capsule solutions: Manufacturers are offering customized capsule solutions to meet the specific needs of pharmaceutical and nutraceutical companies.
In May 2021, Evonik launched a new platform, called EUDRACAP platform, to help the pharmaceutical industry accelerate the speed to market for complex oral drug products in early development stages. EUDRACAP is Evonik's latest system solution built on the company's unique technology platform for advanced drug delivery.
Contact us:
Consegic Business intelligence Pvt Ltd.
Contact no: (US) (505) 715-4344
Email: [email protected]
Other Related Reports:
댓글목록
no comments.